Search results
4 Pharma, Biotech Stocks Poised to Beat Q1 Earnings Estimates
Zacks via Yahoo Finance· 1 year agoThe earnings season has just started for the drug/biotech sector, with bellwether Johnson & Johnson...
4 Biotech Stocks Likely to Outpace Q3 Earnings Estimates
Zacks via Yahoo Finance· 7 months agoAs we near the end of the ongoing earnings season, the scorecard for the Medical sector appears...
Biotech execs share the 3 most important steps companies can take to increase diversity and...
Business Insider via Yahoo News· 2 years agoPhoto_Concepts/Getty Images Nearly 8 out of 10 biotech companies say that diversity is a priority....
A Biotech Startup Used DMT to Successfully Treat Depression
The Daily Beast via Yahoo News· 1 year agoSkouatroulio / GettyA London biotech startup announced Wednesday that it had found success in...
Pharma CEOs are in wait-and-see mode on Mark Cuban's attempt to lower prices on generic drugs. 'It's...
Business Insider via Yahoo News· 1 year agoMark Cuban.Brian Snyder/Reuters The billionaire Mark Cuban wants to change the face of generic...
Royalty Pharma plc (NASDAQ:RPRX) Q3 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoRoyalty Pharma plc (NASDAQ:RPRX) Q3 2022 Earnings Call Transcript November 8, 2022 Royalty Pharma...
Cytokinetics (CYTK) Rises on Reports of Buyout by Novartis
Zacks via Yahoo Finance· 5 months agoShares of Cytokinetics, Incorporated CYTK increased 15.29% after reports of a plausible acquisition...
Here's the Best Big Pharma Stock of the Decade so Far (and It's Not Even Close)
Motley Fool· 8 months agoThe overall stock market has performed well since 2020, despite the COVID-19 pandemic. As things...
JPM24: Nvidia’s AI dreams, Sarepta’s rosy outlook and Jeff Jonas’ new job
BioPharma Dive via Yahoo Finance· 5 months agoBiotechnology investors and executives appeared eager to dive into this year’s J.P. Morgan...
Project Optimus: helping or hindering cancer drug development?
Clinical Trials Arena via Yahoo Finance· 1 month agoAlongside the multitude of guidance documents, recent years have seen the US Food and Drug...